Generic Portal

— Research Explorer

Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/j.ygyno.2022.05.025
Final published version

P. Lof
R. van de Vrie
C. M. Korse
M. D. J. M. van Gent
C. H. Mom
F. M. F. Rosier - van Dunné
W. M. van Baal
H. R. Verhoeve
B. B. J. Hermsen
M. B. Verbruggen
M. Hemelaar
A. M. G. van de Swaluw
H. C. Knipscheer
J. A. F. Huirne
S. M. Westenberg
V. van der Noort
F. Amant
D. van den Broek
C. A. R. Lok

Original language	English
Pages (from-to)	284-291
Number of pages	8
Journal	Gynecologic oncology
Volume	166
Issue number	2
Early online date	2022
DOIs	https://doi.org/10.1016/j.ygyno.2022.05.025
Publication status	Published - Aug 2022

Research areas

HE4, Ovarian mass, RMI

ID: 24374061